Wow that was a fascinating read! A thousand thanks for following through and posting it here.
Horizon clearly believes CERP has no revenue and seems to be making an excellent case towards exercising the rights given to it under the loan agreements.
I guess it's a race against time at this point. MammaCangura sales don't start til April, though we can assume CERP would be earning as early as March to fill the preorders so the launch goes smoothly. The question is whether CERP has proof of near-term, inevitable income that defeats Horizon's statement of no operating capital.
If not, that's all she wrote folks! To be honest, I wouldn't mind seeing the Seymour facility taken over by someone else that stays in the bioplastics business. A new set of management may be just what CERP needs. I'd be willing to buy if that were the case.
Thanks again.